Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
FIS Reports Strong Third Quarter 2024 Results and Raises Full-Year Outlook
-
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
-
Qiddiya and leading tech company Globant agree a landmark partnership to make Saudi Arabia's Qiddiya City one of the world's most immersive entertainment hubs
-
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
-
AAON To Present At Baird 2024 Global Industrials Conference On November 12-13, 2024
-
NAPCO Reports Revenues, Net Income and Adjusted EBITDA* for Q1 of Fiscal 2025
-
A Global Movement for Peace Sparks Young Creatives into Action
-
4Front Ventures Corp. Announces Official Ribbon Cutting of Its 250,000 Sq. Ft. Cultivation and Production Facility in Illinois, Now Operational and Serving Mission Dispensaries and the State of Illino
-
Knife River Corporation Reports Third Quarter Financial Results
-
enCore Energy Provides 5 Year Uranium Contracting Strategy Outlook
-
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
-
Urano Energy Announces Completion of Name Change and Appointment of Dr. Douglas Underhill to the Board of Directors
-
Grounded Lithium Announces Commencement of 2024 Field Program and Selection of Stantec as Lead Author for Pre-Feasibility Study
-
Opthea to Participate in November Investor Conferences
-
H.I.G. Capital and Thoma Bravo to Acquire CompTIA Brand and Products
-
Arsenal Capital Partners Adds Joshua Schultz as an Operating Partner
-
Zoetis Announces Third Quarter 2024 Results
-
Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease
-
theLotter: Why Mega Millions' Planned Overhaul Is a 'Mega' Win for Players
-
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
-
OS Therapies to Present at The Spartan Capital Investor Conference
-
The New Terminal One at JFK Announces Leadership Team Appointments
-
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
-
MY DR NOW Expands Healthcare Accessibility with New Glendale Location
-
Corero Network Security Joins OTCQX Best Market, Expanding US Reach and Investor Visibility
-
Korea Zinc: Young Poong Ordered to Suspend Operations Due to Environmental Violations, Raising Concerns Over Global Zinc Supply
-
Dentalcorp to Deploy Leading AI Solutions Across its Network to Enhance Patient Care and Practice Performance
-
Flow Beverage Corp. Announces Changes to the Board of Directors
-
Inspirity Health Partners, a HumanityCorp and Mayo Clinic Supply Chain Management Partnership, Helping Hospitals Improve Margins
-
Flow Beverage Corp. Closes $4.1 Million Secured Term Loan
-
KalVista Pharmaceuticals Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust
-
Algoma Central Corporation Reports Financial Results for the 2024 Third Quarter
-
RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer
-
Siyata Mobile Secures New $2.5 Million Order
-
Sono-Tek Announces Share Buyback
-
Bridge Carbon Launches to Deliver High-Quality, High-Impact Carbon Reduction Projects to Address Climate Change and Drive Sustainable Development
-
D-Wave Regains Compliance with NYSE Continued Listing Standards
-
Meet the Yaber L2 Series: Your New Go-To for Entry-Level Projectors
-
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
-
ZYUS Life Sciences Corporation Announces Unsecured Loan
-
eRESI Secures Additional Investment from KKR
-
ANOS Capital Expands Team with the Hiring of Five New Traders
-
SymphonyAI Achieves Industrial Connected Worker Leadership Position
-
Pebblebrook Hotel Trust Extends $787 Million in Debt Maturities, Enhancing Financial Flexibility
-
Forest Charter School Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students
-
908 Devices to Participate in Upcoming Investor Conferences
-
Güntner Appoints Michael Bauer as Global Vice President for Growth and Success
-
Better Choice Company to Host Third Quarter 2024 Financial Results Conference Call on November 12th at 4:30 p.m. ET
-
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
-
Village Farms International Selected to Testify at Marijuana Rescheduling Hearing
